PATENT CLAIM ANALYSIS

Application Number: 15900211
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacement compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases

Claim (Index 5):
The method of  claim 1 , wherein each of the two or more human IgG4 Fc domains further comprises a tailpiece region, and wherein the tailpiece region is an IgM CH4 domain.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.33333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15483873', '12602609', '14221148', '14032597', '13971584']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8720998364067635
- 35 USC 102 Novelty (BERT): 0.7851686185005308
- Combined Prediction Score: 0.8634067146161402
- Mean Citation Score: 747.057564
- Max Citation Score: 938.06476
- Similarity Product: 904.4527617790508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test